News | August 12, 2021
KK Pant is the new NPPA chairman
It plays a pivotal role in monitoring pharmaceutical pricing
It plays a pivotal role in monitoring pharmaceutical pricing
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
The company has strong product launches both in India and overseas
The company has also applied to DCGI for Emergency Use Authorization (EUA) for ZyCoVD, the world's first Plasmid DNA Vaccine
The profits were bolstered by the Boehringer Ingelheim MEK program income
Formulation business grew by 15 per cent in the quarter
The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
The company expects revenue growth of 10-15 per cent in the US
India business contributes to a stellar performance
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
Subscribe To Our Newsletter & Stay Updated
